Investing.com -- Immunome, Inc. (NASDAQ: IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company, known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback